Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02001805Unknown

Marathon Runners Compared to Sedentary Matched Control Subjects

Role: lead

NCT01584960Not ApplicableCompleted

The Effect of Endurance Training in Patients With Prostate Cancer

Role: lead

NCT01378208Not ApplicableCompleted

How Often Should We Eat

Role: lead

NCT01676480Not ApplicableCompleted

The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

Role: lead

All 4 trials loaded